Literature DB >> 90502

Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols.

M Kawakami, M Imawari, D S Goodman.   

Abstract

Cholecalciferol (vitamin D3) and its 25-hydroxy metabolite are transported in plasma bound to a specific protein, the binding protein for cholecalciferol and its metabolites (DBP). DBP is identical with the group-specific component (Gc) proteins, which are known to display genetic polymorphism. Studies were conducted to explore whether or not major differences in the transport of cholecalciferol and its biological metabolites might exist among persons with different Gc phenotypes. Detailed quantitative studies were first carried out on the interaction of 25(OH)D3 with DBP in 21 different samples of serum, representing eight different Gc phenotypes. The studies used a filter disc assay method that provided highly reproducible quantitative results with cholecalciferol-related sterols. The Gc phenotypes studied included the three common types (Gc 1-1, 2-1, and 2-2) and several uncommon genetic variants (Gc Ab-Ab, Ab-1, Ab-2, Chip-1, and Chip-2). The binding affinities for 25(OH)D3 observed with these different sera were all fairly similar to each other. More extensive studies were then conducted to compare the binding of four cholecalciferol-related sterols to each of three genetic variants of DBP, by using sera from homozygous persons with the Gc 1-1, Gc 2-2 and Gc Ab-Ab phenotypes. The ligands tested included cholecalciferol, 25(OH)D3, 1,25(OH)2D3, and 24(R) 25(OH)2D3. The affinities of the three genetic types of DBP/Gc protein were found to be similar for each of the four cholecalciferol-related sterols. The apparent association constants for 25(OH)D3 and 24,25(OH)2D3 were similar (approx. 1--2 x 10(8) M-1); lesser affinities were observed for 1,25(OH)2D3 (kA approx. 1 x 10(7) M-1) and for cholecalciferol (kA approx. 3--4 x 10(5) M-1). Thus the common genetic variants of DBP/Gc protein, and the uncommon genetic variants studied here, all appear to have similar binding properties for cholecalciferol and its several metabolites.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90502      PMCID: PMC1186639          DOI: 10.1042/bj1790413

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Measurement of 25-hydroxyvitamin D3 in serum.

Authors:  R Bouillon; P V Kerkhove; P De Moor
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

2.  TWO GENETIC VARIANTS OF THE GROUP-SPECIFIC COMPONENT OF HUMAN SERUM: GC CHIPPEWA AND GC ABORIGINE.

Authors:  H CLEVE; R L KIRK; W C PARKER; A G BEARN; L E SCHACHT; H KLEINMAN; W R HORSFALL
Journal:  Am J Hum Genet       Date:  1963-12       Impact factor: 11.025

3.  The Gc-system. Immuno-electrophoretic studies of normal human sera with special reference to a new genetically determined system (Gc).

Authors:  J HIRSCHFELD
Journal:  Prog Allergy       Date:  1962

4.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

5.  Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography.

Authors:  G Jones
Journal:  Clin Chem       Date:  1978-02       Impact factor: 8.327

6.  Seasonal variations in serum 25-hydroxycholecalciferol in healthy people.

Authors:  M McLaughlin; P R Raggatt; A Fairney; D J Brown; E Lester; M R Wills
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

7.  Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol.

Authors:  J G Haddad; L Hillman; S Rojanasathit
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

8.  Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.

Authors:  J G Haddad; J Walgate
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay.

Authors:  J A Eisman; A J Hamstra; B E Kream; H F DeLuca
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

10.  Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum.

Authors:  M Imawari; D S Goodman
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

View more
  18 in total

1.  Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations.

Authors:  Janice B Schwartz; J Christopher Gallagher; Rolf Jorde; Vivian Berg; Jennifer Walsh; Richard Eastell; Amy L Evans; Simon Bowles; Kim E Naylor; Kerry S Jones; Inez Schoenmakers; Michael Holick; Eric Orwoll; Carrie Nielson; Martin Kaufmann; Glenville Jones; Roger Bouillon; Jennifer Lai; Davide Verotta; Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

2.  Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.

Authors:  Clark M Henderson; Susan L Fink; Hanan Bassyouni; Bob Argiropoulos; Lindsay Brown; Thomas J Laha; Konner J Jackson; Raymond Lewkonia; Patrick Ferreira; Andrew N Hoofnagle; Julien L Marcadier
Journal:  N Engl J Med       Date:  2019-03-21       Impact factor: 91.245

3.  Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.

Authors:  Chen Yuan; Irene M Shui; Kathryn M Wilson; Meir J Stampfer; Lorelei A Mucci; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

4.  24,25-Dihydroxyvitamin d3 and vitamin D status of community-dwelling black and white Americans.

Authors:  Anders H Berg; Camille E Powe; Michele K Evans; Julia Wenger; Guillermo Ortiz; Alan B Zonderman; Pirianthini Suntharalingam; Kathryn Lucchesi; Neil R Powe; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Clin Chem       Date:  2015-04-28       Impact factor: 8.327

Review 5.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

6.  Serum concentrations of vitamin D-binding protein (group-specific component) in cystic fibrosis.

Authors:  D Coppenhaver; F Kueppers; D Schidlow; D Bee; J N Isenburg; D R Barnett; B H Bowman
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.

Authors:  Kevin M Curtis; Kristina K Aenlle; Bernard A Roos; Guy A Howard
Journal:  Mol Endocrinol       Date:  2014-03-05

8.  Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).

Authors:  J Arnaud; J Constans
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

9.  Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.

Authors:  R Bouillon; F A Van Assche; H Van Baelen; W Heyns; P De Moor
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 10.  Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status?

Authors:  Daniel Bikle; Roger Bouillon; Ravi Thadhani; Inez Schoenmakers
Journal:  J Steroid Biochem Mol Biol       Date:  2017-01-16       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.